Abstract

Duffy (Fy) blood group antigens are located on seven-transmembrane glycoprotein expressed on erythrocytes and endothelial cells, which acts as atypical chemokine receptor (ACKR1) and malarial receptor. The biological role of the Duffy glycoprotein has not been explained yet. It is suggested that Duffy protein modulate the intensity of the inflammatory response. The Duffy blood group system consists of two major antigens, Fya and Fyb, encoded by two codominant alleles designated FY*A and FY*B which differ by a single nucleotide polymorphism (SNP) at position 125G>A of the FY gene that results in Gly42Asp amino acid change in the Fya and Fyb antigens, respectively. The presence of antigen Fya and/or Fyb on the erythrocytes determine three Duffy-positive phenotypes: Fy(a+b-), Fy(a-b+) and Fy(a+b+), identified in Caucasian population. The Duffy-negative phenotype Fy(a-b-), frequent in Africans, but very rare in Caucasians, is defined by the homozygous state of FY*B-33 alleles. The FY*B-33 allele is associated with a SNP -33T>C in the promoter region of the FY gene, which suppresses erythroid expression of this gene without affecting its expression in other tissues. The FY*X allele, found in Caucasians, is correlated with weak expression of Fyb antigen. Fyx antigen differs from the native Fyb by the Arg89Cys and Ala100Thr amino acid substitutions due to SNPs: 265C>T and 298G>A in FY*B allele. The frequency of the FY alleles shows marked geographic disparities, the FY*B-33 allele is predominant in Africans, the FY*B in Caucasians, while the FY*A allele is dominant in Asians and it is the most prevalent allele globally.

References

• 1. Afenyi-Annan A., Kail M., Combs M.R., Orringer E.P., Ashley-Koch A., Telen M.J.: Lack of Duffy antigen expression is associatedwith organ damage in patients with sickle cell disease. Transfusion,2008; 48: 917-924
  Google Scholar
• 2. Akalin E., Neylan J.F.: The influence of Duffy blood group on renalallograft outcome in African Americans. Transplantation, 2003;75: 1496-1500
  Google Scholar
• 3. Albrey J.A., Vincent E.E., Hutchinson J., Marsh W.L., Allen F.H.Jr, Gavin J., Sanger R.: A new antibody, anti-Fy3, in the Duffy bloodgroup system. Vox Sang., 1971; 20: 29-35
  Google Scholar
• 4. Albuquerque S.R., Cavalcante F.O., Sanguino E.C., Tezza L., ChaconF., Castilho L., dos Santos M.C.: FY polymorphisms and vivax malariain inhabitants of Amazonas State, Brazil. Parasitol Res., 2010;106: 1049-1053
  Google Scholar
• 5. Bachelerie F., Ben-Baruch A., Burkhardt A.M., Combadiere C.,Farber J.M., Graham G.J., Horuk R., Sparre-Ulrich A.H., Locati M.,Luster A.D., Mantovani A., Matsushima K., Murphy P.M., Nibbs R.,Nomiyama H., Power C.A., Proudfoot A.E., Rosenkilde M.M., Rot A.,Sozzani S., Thelen M., Yoshie O., Zlotnik A.: International Union ofBasic and Clinical Pharmacology. LXXXIX. Update on the extendedfamily of chemokine receptors and introducing a new nomenclaturefor atypical chemokine receptors. Pharmacol Rev., 2013; 66: 1-79
  Google Scholar
• 6. Bachelerie F., Graham G.J., Locati M., Mantovani A., Murphy P.M.,Nibbs R., Rot A., Sozzani S., Thelen M.: An atypical addition to thechemokine receptor nomenclature: IUPHAR Review 15. Br. J. Pharmacol.,2015; 172: 3945-3949
  Google Scholar
• 7. Bakanay S.M., Ozturk A., Ileri T., Ince E., Yavasoglu S., Akar N.,Uysal Z., Arslan O.: Blood group genotyping in multi-transfused patients.Transfus. Apher. Sci., 2013; 48: 257-261
  Google Scholar
• 8. Bandyopadhyay S., Zhan R., Chaudhuri A., Watabe M., Pai S.K.,Hirota S., Hosobe S., Tsukada T., Miura K., Takano Y., Saito K., PauzaM.E., Hayashi S., Wang Y., Mohinta S., Mashimo T., Iiizumi M., FurutaE., Watabe K.: Interaction of KAI1 on tumor cells with DARC onvascular endothelium leads to metastasis suppression. Nat. Med.,2006; 12: 933-938
  Google Scholar
• 9. Bolton M.J., Garry R.F.: Sequence similarity between the erythrocytebinding domain 1 of the Plasmodium vivax Duffy binding proteinand the V3 loop of HIV-1 strain MN reveals binding residues for theDuffy antigen receptor for chemokines. Virol. J., 2011; 8: 45
  Google Scholar
• 10. Castilho L., Rios M., Pellegrino J.Jr., Saad S.T., Costa F.F., Reid M.E.: A novel FY allele in Brazilians. Vox Sang., 2004; 87: 190-195
  Google Scholar
• 11. Cavasini C.E., de Mattos L.C., Couto A.A., Couto V.S., Gollino Y.,Moretti L.J., Bonini-Domingos C.R., Rossit A.R., Castilho L., MachadoR.L.: Duffy blood group gene polymorphisms among malariavivax patients in four areas of the Brazilian Amazon region. Malar.J., 2007; 6: 167
  Google Scholar
• 12. Chakera A., Seeber R.M., John A.E., Eidne K.A., Greaves D.R.: TheDuffy antigen/receptor for chemokines exists in an oligomeric formin living cells and functionally antagonizes CCR5 signaling throughhetero-oligomerization. Mol. Pharmacol., 2008; 73: 1362-1370
  Google Scholar
• 13. Chaudhuri A., Polyakova J., Zabrzezna V., Williams K., Gulati S.,Pogo A.O.: Cloning of glycoprotein D cDNA, which encodes the majorsubunit of the Duffy blood group system and the receptor forthe Plasmodium vivax malaria parasite. Proc. Natl. Acad. Sci. USA,1993; 90: 10793-10797
  Google Scholar
• 14. Chitnis C.E., Chaudhuri A., Horuk R., Pogo A.O., Miller L.H.: Thedomain on the Duffy blood group antigen for binding Plasmodiumvivax and P. knowlesi malarial parasites to erythrocytes. J. Exp. Med.,1996; 184: 1531-1536
  Google Scholar
• 15. Chittoria A., Mohanty S., Jaiswal Y.K., Das A.: Natural selectionmediated association of the Duffy (FY) gene polymorphisms withPlasmodium vivax malaria in India. PloS One, 2012; 7: e45219
  Google Scholar
• 16. Choe H., Moore M.J., Owens C.M., Wright P.L., Vasilieva N., LiW., Singh A.P., Shakri R., Chitnis C.E., Farzan M.: Sulphated tyrosinesmediate association of chemokines and Plasmodium vivax Duffybinding protein with the Duffy antigen/receptor for chemokines(DARC). Mol. Microb., 2005; 55: 1413-1422
  Google Scholar
• 17. Chown B., Lewis M., Kaita H.: The Duffy blood group systemin Caucasians: Evidence for a new allele. Am. J. Hum. Genet., 1965;17: 384-389
  Google Scholar
• 18. Cotorruelo C., Biondi C., Racca L., Borrás S.G., Racca A.: Duffygenotyping facilitates transfusion therapy. Clin. Exp. Med., 2009;9: 249-251
  Google Scholar
• 19. Cutbush M., Mollison P.L.: The Duffy blood group system. Heredity,1950; 4: 383-389
  Google Scholar
• 20. Czerwiński M.: Grupy krwi – minusy i plusy. Czy antygeny grupowekrwi chronią nas przed chorobami zakaźnymi? Postępy Hig.Med. Dośw., 2015; 69: 703-722
  Google Scholar
• 21. Czerwiński M., Kern J., Grodecka M., Paprocka M., Krop-Wątorek A., Waśniowska K.: Mutational analysis of the N-glycosylation sitesof Duffy antigen/receptor for chemokines. Biochem. Biophys. Res.Commun., 2007; 356: 816-821
  Google Scholar
• 22. Daniels G.: Duffy blood group system. W: Human Blood Groups,3rd edn. Wiley-Blackwell, West Sussex, 2013, 324-341
  Google Scholar
• 23. Darbonne W.C., Rice G.C., Mohler M.A., Apple T., Hebert C.A.,Valente A.J., Baker J.B.: Red blood cells are a sink for interleukin 8,a leukocyte chemotaxin. J. Clin. Invest., 1991; 88: 1362-1369
  Google Scholar
• 24. Donahue R.P., Bias W.B., Renwick J.H., McKusick V.A.: Probableassignment of the Duffy blood group locus to chromosome 1 in man.Proc. Natl. Acad. Sci. USA, 1968; 61: 949-955
  Google Scholar
• 25. Drasar E.R., Menzel S., Fulford T., Thein S.L.: The effect of Duffyantigen receptor for chemokines on severity in sickle cell disease.Haematologica, 2013; 98: e87-e89
  Google Scholar
• 26. Estalote A.C., Proto-Siqueira R., Silva W.A.Jr, Zago M.A., PalatnikM.: The mutation G298A>Ala100Thr on the coding sequence of theDuffy antigen/chemokine receptor gene in non-caucasian Brazilians.Genet. Mol. Res., 2005; 4: 166-173
  Google Scholar
• 27. Flôres M.A., Visentainer J.E., Guelsin G.A., Fracasso Ade S., deMelo FC., Hashimoto M.N., Sell A.M.: Rh, Kell, Duffy, Kidd and Diegoblood group system polymorphism in Brazilian Japanese descendants.Transfus. Apher. Sci., 2014; 50: 123-128
  Google Scholar
• 28. Galinski M.R., Medina C.C., Ingravallo P., Barnwell J.W.: A reticulocyte-binding protein complex of Plasmodium vivax merozoites.Cell, 1992; 69: 1213-1226
  Google Scholar
• 29. Gassner C., Kraus R.L., Dovc T., Kilga-Nogler S., Utz I., MuellerT.H., Schunter F., Schoenitzer D.: Fyx is associated with two missensepoint mutations in its gene and can be detected by PCR-SSP.Immunohematology, 2000; 16: 61-67
  Google Scholar
• 30. Graham G.J.: D6 and the atypical chemokine receptor family:novel regulators of immune and inflammatory processes. Eur. J.Immunol., 2009; 39: 342-351
  Google Scholar
• 31. Grimberg B.T., Udomsangpetch R., Xainli J., McHenry A., PanichakulT., Sattabongkot J., Cui L., Bockarie M., Chitnis C., AdamsJ., Zimmerman P.A., King C.L.: Plasmodium vivax invasion of humanerythrocytes inhibited by antibodies directed against the Duffy bindingprotein. PLoS Med., 2007; 4: e337
  Google Scholar
• 32. Grodecka M., Bertrand O., Karolak E., Lisowski M., WaśniowskaK.: One-step immunopurification and lectinochemical characterizationof the Duffy atypical chemokine receptor from human erythrocytes.Glycoconj J., 2012; 29: 93-105
  Google Scholar
• 33. Grodecka M., Czerwiński M., Duk M., Lisowska E., Waśniowska K.:Analysis of recombinant Duffy protein-linked N-glycans with lectinsand glycosidases. Acta Biochim. Pol., 2010; 57: 49-53
  Google Scholar
• 34. Grodecka M., Waśniowska K.: Interceptory – „ciche” receptorychemokin. Postępy Hig. Med. Dośw., 2007; 61: 231-239
  Google Scholar
• 35. Hadley T.J., David P.H., McGinniss M.H., Miller L.H.: Identificationof an erythrocyte component carrying the Duffy blood groupFya antigen. Science, 1984; 223: 597-599
  Google Scholar
• 36. Hadley T.J., Lu Z.H., Waśniowska K., Martin A.W., Peiper S.C., HesselgesserJ., Horuk R.: Postcapillary venule endothelial cells in kidneyexpress a multispecific chemokine receptor that is structurally andfunctionally identical to the erythroid isoform, which is the Duffyblood group antigen. J. Clin. Invest., 1994; 94: 985-991
  Google Scholar
• 37. Hadley T.J., Peiper S.C.: From malaria to chemokine receptor:the emerging physiologic role of the Duffy blood group antigen.Blood, 1997; 89: 3077-3091
  Google Scholar
• 38. Hai R., Zhang L., Pei Y., Zhao L., Ran S., Han Y., Zhu X., Shen H.,Tian Q., Deng H.: Bivariate genome-wide association study suggeststhat the DARC gene influences lean body mass and age at menarche.Sci. China Life Sci., 2012; 55: 516-520
  Google Scholar
• 39. Handel T.M., Horuk R.: Duffy antigen inhibitors: useful therapeutics for malaria? Trends Parasitol., 2010; 26: 329-333
  Google Scholar
• 40. Hansell C.A., Hurson C.E., Nibbs R.J.: DARC and D6: silent partnersin chemokine regulation? Immunol. Cell Biol., 2011; 89: 197-206
  Google Scholar
• 41. Horton L.W., Yu Y., Zaja-Milatovic S., Strieter R.M., Richmond A.:Opposing roles of murine Duffy antigen receptor for chemokine andmurine CXC chemokine receptor-2 receptors in murine melanomatumor growth. Cancer Res., 2007; 67: 9791-9799
  Google Scholar
• 42. Horuk R., Chitnis C.E., Darbonne W.C., Colby T.J., Rybicki A.,Hadley T.J., Miller L.H.: A receptor for the malarial parasite Plasmodiumvivax: the erythrocyte chemokine receptor. Science, 1993;261: 1182-1184
  Google Scholar
• 43. Howes R.E., Patil A.P., Piel F.B., Nyangiri O.A., Kabaria C.W., GethingP.W., Zimmerman P.A., Barnadas C., Beall C.M., GebremedhinA., Ménard D., Williams T.N., Weatherall D.J., Hay S.I.: The globaldistribution of the Duffy blood group. Nat. Commun., 2011; 2: 266
  Google Scholar
• 44. Hughes L.H., Rossi K.Q., Krugh D.W., O’Shaughnessy R.W.: Managementof pregnancies complicated by anti-Fy(a) alloimmunization.Transfusion, 2007; 47: 1858-1861
  Google Scholar
• 45. Ikin E.W., Mourant A.E., Pettenkofer H.J., Blumenthal G.: Discoveryof the expected haemagglutinin, anti-Fyb. Nature, 1951;168: 1077-1078
  Google Scholar
• 46. Irshaid N.M., Ramadan S., Wester E.S., Olausson P., Hellberg A.,Merza J.Y., Olsson M.L.: Phenotype prediction by DNA-based typingof clinically significant blood group systems in Jordanian blood donors.Vox Sang., 2002; 83: 55-62
  Google Scholar
• 47. Iwamoto S., Li J., Omi T., Ikemoto S., Kajii E.: Identification ofa novel exon and spliced form of Duffy mRNA that is predominanttranscript in both erythroid and postcapillary venule endothelium.Blood, 1996; 87: 378-385
  Google Scholar
• 48. Kangelaris K.N., Sapru A., Calfee C.S., Liu K.D., Pawlikowska L.,Witte J.S., Vittinghoff E., Zhuo H., Auerbach A.D., Ziv E., MatthayM.A.: The association between a Darc gene polymorphism and clinicaloutcomes in African American patients with acute lung injury.Chest, 2012; 141, 1160-1169
  Google Scholar
• 49. Karolak E., Grodecka M., Suchanowska A., Klausa E., BochenekS., Majorczyk E., Czerwiński M., Waśniowska K.: Molecular characterizationof the Fy(a-b-) phenotype in a Polish family. Transfus.Apher. Sci., 2013; 49: 313-317
  Google Scholar
• 50. Kasehagen L.J., Mueller I., Kiniboro B., Bockarie M.J., ReederJ.C., Kazura J.W., Kastens W., McNamara D.T., King C.H., Whalen C.C.,Zimmerman P.A.: Reduced Plasmodium vivax erythrocyte infection inPNG Duffy-negative heterozygotes. PLoS One, 2007; 2: e336
  Google Scholar
• 51. Kempińska-Podhorodecka A., Knap O., Drozd A., KaczmarczykM., Parafiniuk M., Parczewski M., Ciechanowicz A.: Analysis for genotypingDuffy blood group in inhabitants of Sudan, the fourth cataractof the Nile. Malar. J., 2012; 11: 115
  Google Scholar
• 52. Keramati M.R., Shakibaei H., Kheiyyami M.I., Ayatollahi H., BadieiZ., Samavati M., Sadeghian M.H.: Blood group antigens frequenciesin the northeast of Iran. Transfus. Apher. Sci., 2011; 45: 133-136
  Google Scholar
• 53. King C.L., Adams J.H., Xianli J., Grimberg B.T., McHenry A.M.,Greenberg L.J., Siddiqui A., Howes R.E., da Silva-Nunes M., FerreiraM.U., Zimmerman P.A.: Fya/Fyb antigen polymorphism in humanerythrocyte Duffy antigen affects susceptibility to Plasmodium vivaxmalaria. Proc. Natl. Acad. Sci. USA, 2011; 108: 20113-20118
  Google Scholar
• 54. Langhi D.M.Jr., Bordin J.O.: Duffy blood group and malaria. Hematology,2006; 11: 389-398
  Google Scholar
• 55. Lentsch A.B.: The Duffy antigen/receptor for chemokines (DARC)and prostate cancer. A role as clear as black and white? FASEB J.,2002; 16: 1093-1095
  Google Scholar
• 56. Liu J., Guo X., Mohandas N., Chasis J.A., An X.: Membrane remodelingduring reticulocyte maturation. Blood, 2010; 115: 2021-2027
  Google Scholar
• 57. Liu X.F., Li L.F., Ou Z.L., Shen R., Shao Z.M.: Correlation between Duffy blood group phenotype and breast cancer incidence. BMCCancer, 2012; 12: 374
  Google Scholar
• 58. Lopez G.H., Condon J.A., Wilson B., Martin J.R., Liew Y.W., FlowerR.L., Hyland C.A.: A novel FYA allele with the 265T and 298ASNPs formerly associated exclusively with the FYB allele and weakFy(b) antigen expression: implication for genotyping interpretativealgorithms. Vox Sang., 2015; 108: 52-57
  Google Scholar
• 59. Łukasik E., Waśniowska K., Grodecka M., Majorczyk E., CzerwińskiM.: High-resolution melting analysis for genotyping Duffy bloodgroup antigens. Methods Mol. Biol., 2015; 1310: 83-95
  Google Scholar
• 60. Mallinson G., Soo K.S., Schall T.J., Pisacka M., Anstee D.J.: Mutationsin the erythrocyte chemokine receptor (Duffy) gene: the molecularbasis of the Fya/Fyb antigens and identification of a deletion inthe Duffy gene of an apparently healthy individual with the Fy(a-b-)phenotype. Br. J. Haematol., 1995; 90: 823-829
  Google Scholar
• 61. Mathew S., Chaudhuri A., Murty V.V, Pogo A.O.: Confirmation ofDuffy blood group antigen locus (FY) at 1q22q23 by fluorescencein situ hybridization. Cytogenet. Cell Genet., 1994; 67: 68
  Google Scholar
• 62. McMorran B.J., Wieczorski L., Drysdale K.E., Chan J.A., HuangH.M., Smith C., Mitiku C., Beeson J.G., Burgio G., Foote S.J.: Plateletfactor 4 and Duffy antigen required for platelet killing of Plasmodiumfalciparum. Science, 2012; 338: 1348-1351
  Google Scholar
• 63. Mecabo G., Hayashida D.Y., Azevedo-Shimmoto M.M., Vicari P.,Arruda M.M., Bordin J.O., Figueiredo M.S.: Duffy-negative is associatedwith hemolytic phenotype of sickle cell anemia. Clin. Immunol.,2010; 136: 458-459
  Google Scholar
• 64. Meny G.M.: The Duffy blood group system: a review. Immunohematology,2010; 26: 51-56
  Google Scholar
• 65. Michalewska B.: Naturally occurring anti-Fyb + Cw. Vox Sang.,2001; 80: 235
  Google Scholar
• 66. Miller L.H., Baruch D.I., Marsh K., Doumbo O.K.: The pathogenicbasis of malaria. Nature, 2002; 415: 673-679
  Google Scholar
• 67. Miller L.H., Mason S.J., Clyde D.F., McGinniss M.H.: The resistancefactor to Plasmodium vivax in blacks. The Duffy-blood-groupgenotype, FyFy. N. Engl. J. Med., 1976; 295: 302-304
  Google Scholar
• 68. Minten C., Alt C., Gentner M., Frei E., Deutsch U., Lyck R., Schaeren-Wiemers N., Rot A., Engelhardt B.: DARC shuttles inflammatorychemokines across the blood-brain barrier during autoimmunecentral nervous system inflammation. Brain, 2014; 137: 1454-1469
  Google Scholar
• 69. Nichols M.E., Rubinstein P., Barnwell J., Rodriguez de CordobaS., Rosenfield R.E.: A new human Duffy blood group specificitydefined by a murine monoclonal antibody. Immunogenetics andassociation with susceptibility to Plasmodium vivax. J. Exp. Med.,1987; 166: 776-785
  Google Scholar
• 70. Olsson M.L., Smythe J.S., Hansson C., Poole J., Mallinson G., JonesJ., Avent N.D., Daniels G.: The Fyx phenotype is associated witha missense mutation in the Fyb allele predicting Arg89Cys in theDuffy glycoprotein. Br. J. Haematol., 1998; 103: 1184-1191
  Google Scholar
• 71. Parasol N., Cohen N., Zemishlany Z., Lerer B., Kosower N.S.: Duffyantigen/receptor for chemokines (DARC): genotypes in Ashkenaziand Non-Ashkenazi Jews in Israel. Hum Biol., 2001; 73: 307-313
  Google Scholar
• 72. Parasol N., Reid M., Rios M., Castilho L., Harari I., Kosower N.S.:A novel mutation in the coding sequence of the FYB allele of theDuffy chemokine receptor gene is associated with an altered erythrocytephenotype. Blood, 1998; 92: 2237-2243
  Google Scholar
• 73. Peiper S.C., Wang Z.X., Neote K., Martin A.W., Showell H.J., ConklynM.J., Ogborne K., Hadley T.J., Lu Z.H., Hesselgesser J., Horuk R.:The Duffy antigen/receptor for chemokines (DARC) is expressed inendothelial cells of Duffy negative individuals who lack the erythrocytereceptor. J. Exp. Med. 1995; 181: 1311-1317
  Google Scholar
• 74. Perna S.J., Cardoso G.L., Guerreiro J.F.: Duffy blood group genotypesamong African-Brazilian communities of the Amazon region.Genet. Mol. Res., 2007; 6: 166-172
  Google Scholar
• 75. Pisacka M., Vytiskova J., Latinakova A., Koristka M., StrasikovaM.: Molecular background of the Fy(a-b-) phenotype in gypsypopulation living in the Czech and Slovak Republic. Transfusion,2001; 41: 15s
  Google Scholar
• 76. Pittoni V., Vaglio S., Magrini L., Accorinti M., Pivetti-Pezzi P.,Girelli G., Valesini G.: Polymorphism of the Duffy erythrocyte chemokinereceptor in Italian patients with Behçet’s disease. Rheumatol.Int., 2003; 23: 116-120
  Google Scholar
• 77. Pogo A.O., Chaudhuri A.: The Duffy protein: a malarial and chemokinereceptor. Semin. Hematol., 2000, 37: 122-129
  Google Scholar
• 78. Pruenster M., Mudde L., Bombosi P., Dimitrova S., Zsak M., MiddletonJ., Richmond A., Graham G.J., Segerer S., Nibbs R.J., Rot A.:The Duffy antigen receptor for chemokines transports chemokinesand supports their promigratory activity. Nat. Immunol., 2009; 10:101-108
  Google Scholar
• 79. Ranjan A., Chitnis C.E.: Mapping regions containing bindingresidues within functional domains of Plasmodium vivax and Plasmodiumknowlesi erythrocyte-binding proteins. Proc. Natl. Acad. Sci.USA, 96: 1999; 14067-14072
  Google Scholar
• 80. Reid M.E., Denomme G.A.: DNA-based methods in the immunohematologyreference laboratory. Transfus. Apher. Sci., 2011; 44:65-72
  Google Scholar
• 81. Reyes M.A., Illoh O.C.: Hyperhemolytic transfusion reaction attributableto anti-Fy3 in a patient with sickle cell disease. Immunohematology,2008; 24: 45-51
  Google Scholar
• 82. Rios M., Chaudhuri A., Mallinson G., Sausais L., Gomensoro-Garcia A.E., Hannon J., Rosenberger S., Poole J., Burgess G., Pogo O.,Reid M.: New genotypes in Fy(a-b-) individuals: nonsense mutations(Trp to stop) in the coding sequence of either FYA or FYB. Br. J.Haematol., 2000; 108: 448-454
  Google Scholar
• 83. Riwom S., Janvier D., Navenot J.M., Benbunan M., Muller J.Y.,Blanchard D.: Production of a new murine monoclonal antibodywith Fy6 specificity and characterization of the immunopurifiedN-glycosylated Duffy-active molecule. Vox Sang., 1994; 66: 61-67
  Google Scholar
• 84. Roche F., Latini M., Uchimura A., Prisco C., Guilhem J., MedeirosR., Baleotti W., Augusto J., Castilho L., Maria J.: Blood cells, molecules,and diseases DARC (Duffy) and BCAM (Lutheran) reduced expressionin thyroid cancer. Blood Cells Mol. Dis., 2012; 50: 161-165
  Google Scholar
• 85. Sanger R., Race R.R., Jack J.: The Duffy blood groups of New Yorknegroes: the phenotype Fy(a-b-). Br. J. Haematol., 1955; 1: 370-374
  Google Scholar
• 86. Schmid P., Ravenell K.R., Sheldon S.L., Flegel W.A.: DARC allelesand Duffy phenotypes in African Americans. Transfusion, 2012; 52:1260-1267
  Google Scholar
• 87. Schnabel R.B., Baumert J., Barbalic M., Dupuis J., Ellinor P.T.,Durda P., Dehghan A., Bis J.C., Illig T., Morrison A.C., Jenny N.S., KeaneyJ.F. Jr, Gieger C., Tilley C., Yamamoto J.F. i wsp.: Duffy antigenreceptor for chemokines (Darc) polymorphism regulates circulatingconcentrations of monocyte chemoattractant protein-1 and otherinflammatory mediators. Blood, 2010; 115: 5289-5299
  Google Scholar
• 88. Segerer S., Jedlicka J., Wüthrich R.P.: Atypical chemokine receptorsin renal inflammation. Nephron. Exp. Nephrol., 2010; 115:e89-e95
  Google Scholar
• 89. Seixas S., Ferrand N., Rocha J.: Microsatellite variation and evolutionof the human Duffy blood group polymorphism. Mol. Biol.Evol., 2002; 19: 1802-1806
  Google Scholar
• 90. Shen H., Schuster R., Stringer K.F., Waltz S.E., Lentsch A.B.: TheDuffy antigen/receptor for chemokines (DARC) regulates prostatetumor growth. FASEB J., 2006; 20: 59-64
  Google Scholar
• 91. Shimizu Y., Ao H., Soemantri A., Tiwawech D., Settheetham-Ishida W., Kayame O.W., Kimura M., Nishioka T., Ishida T.: Sero- andmolecular typing of Duffy blood group in Southeast Asians and Oceanians.Hum. Biol., 2000; 72: 511-518
  Google Scholar
• 92. Smolarek D., Hattab C., Hassanzadeh-Ghassabeh G., Cochet S.,Gutiérrez C., de Brevern A.G., Udomsangpetch R., Picot J., Grodecka M., Waśniowska K., Muyldermans S., Colin Y., Le Van Kim C.,Czerwiński M., Bertrand O.: A recombinant dromedary antibodyfragment (VHH or nanobody) directed against human Duffy antigenreceptor for chemokines. Cell. Mol. Life Sci., 2010; 67: 3371-3387
  Google Scholar
• 93. Souza-Silva F.A., Torres L.M., Santos-Alves J.R., Tang M.L., SanchezB.A., Sousa T.N., Fontes C.J., Nogueira P.A., Rocha R.S., BritoC.F., Adams J.H., Kano F.S., Carvalho L.H.: Duffy antigen receptor forchemokine (DARC) polymorphisms and its involvement in acquisitionof inhibitory anti-Duffy binding protein II (DBPII) immunity.PLoS One, 2014; 9: e93782
  Google Scholar
• 94. St-Louis M.: Molecular blood grouping of donors. Transfus.Apher. Sci., 2014; 50: 175-182
  Google Scholar
• 95. Tamasauskas D., Powell V., Saksela K., Yazdanbakhsh K.: A homologousnaturally occurring mutation in Duffy and CCR5 leadingto reduced receptor expression. Blood, 2001; 97: 3651-3654
  Google Scholar
• 96. Tanner M.J., Anstee D.J., Mallinson G., Ridgwell K., Martin P.G.,Avent N.D., Parsons S.F.: Effect of endoglycosidase F-peptidyl N-glycosidaseF preparations on the surface components of the humanerythrocyte. Carbohydr. Res., 1988; 178: 203-212
  Google Scholar
• 97. Thobakgale C.F., Ndung’u T.: Neutrophil counts in persons ofAfrican origin. Curr. Opin. Hematol., 2014; 21: 50-57
  Google Scholar
• 98. Tournamille C., Blancher A., Le Van Kim C., Gane P., Apoil P.A.,Nakamoto W., Cartron J.P., Colin Y.: Sequence, evolution and ligandbinding properties of mammalian Duffy antigen/receptor for chemokines.Immunogenetics, 2004; 55: 682-694
  Google Scholar
• 99. Tournamille C., Colin Y., Cartron J.P., Le Van Kim C.: Disruptionof a GATA motif in the Duffy gene promoter abolishes erythroidgene expression in Duffy-negative individuals. Nat. Genet., 1995;10: 224-228
  Google Scholar
• 100. Tournamille C., Filipe A., Waśniowska K., Gane P., Lisowska E.,Cartron J.P., Colin Y., Le Van Kim C.: Structure-function analysis ofthe extracelluar domains of the Duffy antigen/receptor for chemokines:characterization of antibody and chemokine binding sites. Br.J. Haematol., 2003; 122: 1014-1023
  Google Scholar
• 101. Tournamille C., Le Van Kim C., Gane P., Le Pennec P.Y., RoubinetF., Babinet J., Cartron J.P., Colin Y.: Arg89Cys substitution results invery low membrane expression of the Duffy antigen/receptor forchemokines in Fyx individuals. Blood, 1998; 92: 2147-2156
  Google Scholar
• 102. Tsuneyama H., Uchikawa M., Shinozaki K., Nakajima. K., JujiT.: A deletion in the Duffy gene of an apparently healthy individualwith the Fy(a-b-) phenotype. Transfusion, 2000; 40: 116S
  Google Scholar
• 103. Ulvmar M.H., Hub E., Rot A.: Atypical chemokine receptors.Exp. Cell Res., 2011; 317: 556-568
  Google Scholar
• 104. Vergara C., Tsai Y.J., Grant A.V., Rafaels N., Gao L., Hand T.,Stockton M., Campbell M., Mercado D., Faruque M., Dunston G.,Beaty T.H., Oliveira R.R., Ponte E.V., Cruz A.A. i wsp.: Gene encodingDuffy antigen/receptor for chemokines is associated with asthmaand IgE in three populations. Am. J. Respir. Crit. Care Med., 2008;178: 1017-1022
  Google Scholar
• 105. Voruganti V.S., Laston S., Haack K., Mehta N.R., Smith C.W., ColeS.A., Butte N.F., Comuzzie A.G.: Genome-wide association replicatesthe association of Duffy antigen receptor for chemokines (DARC)polymorphisms with serum monocyte chemoattractant protein-1(MCP-1) levels in Hispanic children. Cytokine, 2012; 60: 634-638
  Google Scholar
• 106. Wang J., Ou Z.L., Hou Y.F., Luo J.M., Shen Z.Z., Ding J., Shao Z.M.:Enhanced expression of Duffy antigen receptor for chemokines bybreast cancer cells attenuates growth and metastasis potential. Oncogene, 2006; 25: 7201-7211
  Google Scholar
• 107. Waśniowska K.: Chemokiny – perspektywy zastosowania związkówblokujących ich działanie w terapii. Postępy Hig. Med. Dośw.,2004; 58: 37-46
  Google Scholar
• 108. Waśniowska K., Blanchard D., Janvier D., Wang Z.X., Peiper S.C.,Hadley T.J., Lisowska E.: Identification of the Fy6 epitope recognizedby two monoclonal antibodies in the N-terminal extracellular portionof the Duffy antigen receptor for chemokines. Mol. Immunol,.1996; 33: 917-923
  Google Scholar
• 109. Waśniowska K., Czerwinski M., Jachymek W., Lisowska E.: Expressionand binding properties of a soluble chimeric protein containingthe N-terminal domain of the Duffy antigen. Biochem. Biophys.Res. Commun., 2000; 273: 705-711
  Google Scholar
• 110. Waśniowska K., Eichenberger P., Kugele F., Hadley T.J.: Purificationof a 28 kDa non-aggregating tryptic peptide of the Duffy bloodgroup protein. Biochem. Biophys. Res. Commun. 1993; 192: 366-372
  Google Scholar
• 111. Waśniowska K., Lisowska E., Halverson G.R., Chaudhuri A., ReidM.E.: The Fya, Fy6 and Fy3 epitopes of the Duffy blood group systemrecognized by new monoclonal antibodies: identification of a linearFy3 epitope. Br. J. Haematol. 2004; 124: 118-122
  Google Scholar
• 112. Waśniowska K., Petit-LeRoux Y., Tournamille C., Le van Kim C.,Cartron J.P., Colin Y., Lisowska E., Blanchard D.: Structural characterizationof the epitope recognized by the new anti-Fy6 monoclonalantibody NaM 185-2C3. Transfus. Med., 2002; 12: 205-211
  Google Scholar
• 113. Watorek E., Boratyńska M., Hałoń A., Klinger M.: Anti-Fya antibodiesas the cause of an unfortunate post-transplant course in renaltransplant recipient. Ann Transplant., 2008; 13: 48-52
  Google Scholar
• 114. Went R., Wright J., Webster R., Stamps R.: Anti-Fy3 in sicklecell disease: a difficult transfusion problem. Br. J. Haematol., 2009;144: 621-622
  Google Scholar
• 115. Whittall C., Kehoe O., King S., Rot A., Patterson A., MiddletonJ.: A chemokine self-presentation mechanism involving formationof endothelial surface microstructures. J. Immunol., 2013;190: 1725-1736
  Google Scholar
• 116. Yazdanbakhsh K., Rios M., Storry J.R., Kosower N., Parasol N.,Chaudhuri A., Reid M.E.: Molecular mechanisms that lead to reducedexpression of Duffy antigens. Transfusion, 2000; 40: 310-320
  Google Scholar
• 117. Zhao Y., Mangalmurti N. S., Xiong Z., Prakash B., Guo F., StolzD. B., Lee J. S.: Duffy antigen receptor for chemokines mediates chemokineendocytosis through a macropinocytosis-like process inendothelial cells. PLoS One, 2011; 6: e29624
  Google Scholar
• 118. Zhu Z., Sun Z., Wang Z., Guo P., Zheng X., Xu H.: Prognosticimpact of atypical chemokine receptor expression in patients withgastric cancer. J. Surg. Res., 2013; 183: 177-183
  Google Scholar
• 119. Zimmerman P.A., Ferreira M.U., Howes R.E., Mercereau-PuijalonO.: Red blood cell polymorphism and susceptibility to Plasmodiumvivax. Adv. Parasitol., 2013; 81: 27-76
  Google Scholar
• 120. Zimmerman P.A., Woolley I., Masinde G.L., Miller S.M., McNamaraD.T., Hazlett F., Mgone C.S., Alpers M.P., Genton B., Boatin B.A.,Kazura J.W.: Emergence of FY Anull in a Plasmodium vivax-endemicregion of Papua New Guinea. Proc. Natl. Acad. Sci. USA, 1999; 96:13973-13977
  Google Scholar

Full text